Symmetry Medical Appoints Jose Fernandez Senior Vice President of New Product Development

WARSAW, Ind., July 1 /PRNewswire-FirstCall/ — Symmetry Medical, Inc. (NYSE:
SMA), a leading independent provider of products to the global orthopedic device
industry and other medical markets, announced today it has appointed Jose
Fernandez to the newly created position of Senior Vice President of New Product
Development. Mr. Fernandez brings a successful management philosophy of proven
product development and an impressive intellectual property portfolio in both
the cardiovascular and orthopedic device industries. Previously Mr. Fernandez
served as Vice President of Research and Development with Disc Motion
Technologies and held various management positions in product development with
Cordis Neurovascular, a Johnson & Johnson company.

“We welcome Jose to the Symmetry Medical family and look forward to his future
contributions to our growing product development portfolio,” stated Brian Moore,
President, and Chief Executive Officer of Symmetry Medical. “Symmetry’s strong
OEM relationships and direct sales channel to specialty surgeons through our SSI
subsidiary positions the Company to benefit from an expanded offering of
proprietary surgical products. This appointment demonstrates our commitment to
these customers and strengthens our position as a diversified and leading
company in the medical device industry.”

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related
instruments and cases to the orthopedic device industry. The Company also
designs, develops and produces these products for companies in other segments of
the medical device market, including arthroscopy, dental, laparoscopy,
osteobiologic and endoscopy sectors and provides limited specialized products
and services to non-healthcare markets, such as the aerospace market.

Forward-Looking Statements

Statements in the press release regarding Symmetry Medical Inc.’s business,
which are not historical facts, may be “forward-looking statements” that involve
risks and uncertainties, within the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements are
predictive in nature and are frequently identified by the use of terms such as
“may,” “will,” “should,” “expect,” “believe,” “estimate,” “intend,” and similar
words indicating possible future expectations, events or actions. Such
predictive statements are not guarantees of future performance, and actual
results could differ materially from our current expectations. Certain factors
that could cause actual results to differ include: the loss of one or more
customers; the development of new products or product innovations by our
competitors; product liability; changes in management; changes in conditions
effecting the economy, orthopedic device manufacturers or the medical device
industry generally; and changes in government regulation of medical devices and
third-party reimbursement practices. We refer you to the “Risk Factors” and
“Forward Looking Statements” sections in the Company’s most recent Annual Report
on Form 10-K filed with the Securities and Exchange Commission as well as the
Company’s other filings with the SEC, which are available on the SEC’s Web site
at www.sec.gov.

Investors/Media: Contact:
The Ruth Group Symmetry Medical Inc.
Nick Laudico/Jason Rando Fred L. Hite
(646) 536-7030/7025 Senior Vice President
nlaudico@theruthgroup.com Chief Financial Officer
jrando@theruthgroup.com (574) 371-2218

SOURCE Symmetry Medical, Inc.